TL;DR
Get everyday helpers delivered free with Prime
- Fast, free delivery on millions of items
- Prime Video, Amazon Music and more included
- Member-only deals all year
Researchers at the University Hospital of Bonn and the University of Bonn directly reprogrammed human red blood cell precursors into neural stem cells in laboratory conditions. They reported that the cells’ epigenetic age declined gradually, with cells from an 80-year-old showing a molecular age below 20 years; the work is a research model, not a treatment.
Researchers at the University Hospital of Bonn and the University of Bonn report that they converted human red blood cell precursors directly into neural stem cells in laboratory conditions, while the cells’ epigenetic age markers declined. In one example, cells from an 80-year-old donor reached a measured molecular age of less than 20 years, a finding that may help scientists study how cellular aging changes during reprogramming; it does not show that human tissues or brains can be rejuvenated in a patient.
The team used transcription factors to change which genetic instructions the blood-cell precursors followed, directing them toward a neural stem-cell identity. The researchers say this route bypassed an intermediate pluripotent stem-cell stage, a state with the potential to develop into many cell types. The work is described in the journal Aging Cell in a paper titled “Protracted Fate Acquisition and Epigenetic De-Aging During Induced Neural Stem Cell Conversion of Human Blood Cells.”
To assess age-related changes, the researchers measured epigenetic clocks, which track chemical modifications to DNA associated with aging. Such marks do not alter the DNA sequence itself, but are linked to how genetic information is read. The team reports that these measures shifted toward a younger molecular age during conversion. The report also says the researchers found the resulting cells behaved like young cells, though the supplied account does not give the full set of tests or their results.
The process unfolded gradually and could be followed for more than 100 days, according to the report. One example described a roughly 60-year drop in measured molecular age after 50 days. The study authors say the extended timeline could let researchers examine which factors or substances speed up or slow down the clock changes as cells acquire a new identity.
A Slow Model for Studying Cell Aging
The main immediate value is as a laboratory model, rather than a proposed therapy. Because the age-marker changes reportedly take place over weeks, researchers may be able to follow the sequence of reprogramming and investigate how cell identity and age-related marks change together. That could help distinguish processes that occur during a cell’s conversion from those that simply accompany it.
The work is also relevant to neuroscience because age is a major risk factor for neurodegenerative diseases, including Alzheimer’s disease, as Bonn researcher Oliver Brüstle noted. But the findings do not establish that this method prevents or treats such conditions. The experiments concern cells grown and reprogrammed outside the body; any clinical use would require substantial further research on safety, function, and whether the approach works in people.
As an affiliate, we earn on qualifying purchases.
Direct Conversion Avoids a Stem-Cell Stage
Cells in the body share the same basic genetic makeup but become specialized as they develop. A mature blood cell does not naturally turn into a nerve cell. In laboratory reprogramming, scientists use transcription factors to alter the instructions a cell follows and guide it toward another identity.
Earlier approaches to obtaining neural stem cells from blood cells often used two steps: first producing pluripotent stem cells, then directing those cells to become neural stem cells. The Bonn team instead reports a direct conversion. The source account says previous Bonn work found that nerve cells produced by related methods formed connections with existing neurons after transplantation into mouse brains. That earlier animal result is separate from the current study and does not show that the current cell-conversion method is ready for treatment.
““Using this method, we have directly converted red blood cell precursors into neural stem cells.””
— Prof. Oliver Brüstle, director of the Institute of Reconstructive Neurobiology at the University Hospital of Bonn
What the Cell-Age Measure Shows
The reported molecular age is based on epigenetic clock measurements, not a demonstration that a donor’s body or brain became younger. The supplied report does not specify the number of donors, the complete experimental methods, or how the age-clock result varied across samples. It also does not establish how long the younger molecular profile lasts after conversion or whether all resulting cells have the same functional properties.
It remains unclear whether the technique can be adapted safely to living people, whether it would produce useful cells at scale, or whether it could have any effect on disease. The study describes laboratory cell reprogramming; no human treatment trial or clinical benefit is reported.
Testing the Reprogramming Timeline
The researchers say the gradual reset gives them a way to investigate factors that may accelerate or slow epigenetic age changes during direct conversion. The paper, published in Aging Cell, provides the basis for follow-up work on the mechanisms involved. The source report does not name a next clinical milestone or provide a timeline for testing the approach in patients.
For now, the key next step is further laboratory study of how cells acquire neural stem-cell identity and how their age markers change during that process. Any future application to neurodegenerative disease would depend on evidence beyond the cell-culture findings reported here.
Key Questions
What did the Bonn researchers do?
They report directly reprogramming human red blood cell precursors into neural stem cells in laboratory conditions, without first converting them into pluripotent stem cells.
What does a molecular age below 20 mean?
It refers to a result from epigenetic age markers measured in the cells. It does not mean the donor or the donor’s body became younger.
Could this method treat Alzheimer’s disease?
The study does not report a treatment or test in patients. It presents a cell-culture research model that may help scientists study aging and reprogramming; clinical use remains unestablished.
Why is the slow process useful to researchers?
The team says the clock changes could be followed for more than 100 days. That may help researchers investigate which factors affect the pace of cellular reprogramming and age-marker changes.
Source: rss
Halloween Picks
halloween
As an affiliate, we earn on qualifying purchases.
